COMPANY
Tiba Biotech LLC
Funding and NIH signals
- NIH award NIH awarded $397K (SBIR Phase I 1R43HL184887-01A1, new, notice Aug 3, 2026). NIH RePORTER 1R43HL184887-01A1 (Aug 3, 2026)
Evidence (1 event)
- Aug 3, 2026 · NIH RePORTER 1R43HL184887-01A1
Organization: TIBA BIOTECH, LLC; City/State: CAMBRIDGE, MA; Project number: 1R43HL184887-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-03; FY total cost (award amount): 396805; Administering IC: National Heart Lung and Blood Institute; Project title: Lung-targeting delivery of small interfering RNA for pulmonary therapeutics; Organization type: Domestic For-Profits
- Aug 3, 2026 · NIH RePORTER 1R43HL184887-01A1
Timeline
- Grant Government grant — SBIR: $396,805 (annual award, as published), announced Aug 3, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
- Grant Government grant — SBIR: $399,300 (annual award, as published), announced Sep 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗
- Grant Government grant — SBIR: $965,715 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Funding
- Government grant — SBIR: $396,805 (annual award, as published), announced Aug 3, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
- Government grant — SBIR: $399,300 (annual award, as published), announced Sep 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗
- Government grant — SBIR: $965,715 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
NIH awards 5
- NIH award 5R44AI167158-03 FY2024: $965,678 awarded for that fiscal year; activity R44 (SBIR); PI CHAHAL, JASDAVE; recipient as written: TIBA BIOTECH, LLC, CAMBRIDGE, MA. Rapid response to pandemic influenza via multi source ↗
- NIH award 2R44AI167158-02 FY2023: $966,637 awarded for that fiscal year; activity R44 (SBIR); PI CHAHAL, JASDAVE; recipient as written: TIBA BIOTECH, LLC, CAMBRIDGE, MA. Rapid response to pandemic influenza via multi source ↗
- NIH award 1R43AI165194-01A1 FY2022: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI MANDL, CHRISTIAN W.; recipient as written: TIBA BIOTECH, LLC, CAMBRIDGE, MA. Low-dose RNA vaccine platform for tickbo source ↗
- NIH award 1R43AI167158-01A1 FY2022: $284,906 awarded for that fiscal year; activity R43 (SBIR); PI MANDL, CHRISTIAN W.; recipient as written: TIBA BIOTECH, LLC, CAMBRIDGE, MA. Rapid response to pandemic influenza via source ↗
- NIH award 1R43AI162469-01 FY2021: $278,957 awarded for that fiscal year; activity R43 (SBIR); PI MANDL, CHRISTIAN W.; recipient as written: TIBA BIOTECH, LLC, CAMBRIDGE, MA. RNA-based multi-antigen vaccine for SARS-C source ↗